INTELENCE

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug INTELENCE contains one active pharmaceutical ingredient (API):

1 Etravirine UNII 0C50HW4FO1 - ETRAVIRINE

Etravirine is an non-nucleoside reverse transcriptase inhibitors (NNRTI) of human immunodeficiency virus type 1 (HIV-1). Etravirine binds directly to reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by causing a disruption of the enzyme’s catalytic site. Read about Etravirine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INTELENCE Tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J05AG04	Etravirine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AG Non-nucleoside reverse transcriptase inhibitors
Discover more medicines within J05AG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10301E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514507601116211, 514514070026903
Country: CA	Health Products and Food Branch	Identifier(s): 02306778, 02375931, 02396750
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1951-MEE-0316, 29623-02-11
Country: EE	Ravimiamet	Identifier(s): 1381643, 1552788, 1619254
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 08468002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 073027
Country: FR	Base de données publique des médicaments	Identifier(s): 63514730, 64044237, 66595716
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 142054, 198567
Country: HK	Department of Health Drug Office	Identifier(s): 61470
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6394, 7256
Country: JP	医薬品医療機器総合機構	Identifier(s): 6250033F1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1033738, 1064023, 1070790
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 347M2008
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 100463, 119709, 88315
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13404, 14722
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100198482, 100261329, 100302175
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W53549001, W61897001, W61898001
Country: SG	Health Sciences Authority	Identifier(s): 13597P, 14535P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593015298
Country: US	FDA, National Drug Code	Identifier(s): 59676-570, 59676-571, 59676-572
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/20.2.8/0780, 48/20.2.8/1301